Sarepta stock rocketed Friday after hitting a “grand slam” approval that expands the market for its Duchenne muscular dystrophy gene therapy more than tenfold, according to one estimate. ↑ X NOW PLAYING CRSP Stock On Wild Ride After FDA’s Historic Approval. These Gene Editing Treatments Could Come Next. The gene therapy, dubbed Elevidys, already had […]
Read the full story on Backfire News Extreme Road Rage Driver Catapults Motorcyclist Off Bridge 34-year-old Nikesh Mistry from Milton Keynes has been sentenced to nearly five years in prison for his aggressive actions, which led to a motorcyclist being thrown off a bridge. The incident, characterized by authorities as “extreme” road rage, occurred on […]
Novartis (NVS) agreed late Monday to buy German drugmaker MorphoSys (MOR) for roughly $2.9 billion, and the biotech stock catapulted to a nearly three-year high.
Biotech stock Longboard Pharmaceuticals (LBPH) launched to a record high Tuesday, catapulting as much as 326%, after the company announced promising test results for a seizure treatment.
Novartis (NVS) expanded its gene therapy collaboration with Voyager Therapeutics (VYGR) on Monday. VYGR stock rocketed above its 200-day line for the first time in four months.